MUMBAI (Reuters) - India's Dr. Reddy's Laboratories Ltd. said on Saturday it has received a U.S. drug regulator approval for the generic version of Geodon capsules, that are used to treat schizophrenia.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/MRWjeqEawZU/us-india-reddys-geodon-idUSTRE8220B920120303
top news recent news save money travel make money best news
No comments:
Post a Comment